Folger Hill Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-75,019
| Closed | -$9.13M | – | 289 |
|
|
2017
Q2 | $9.13M | Buy |
75,019
+25,720
| +52% | +$3.13M | 0.82% | 37 |
|
|
2017
Q1 | $5.98M | Buy |
49,299
+24,799
| +101% | +$3.01M | 0.48% | 66 |
|
|
2016
Q4 | $3M | Buy |
24,500
+3,970
| +19% | +$486K | 0.27% | 108 |
|
|
2016
Q3 | $2.52M | Sell |
20,530
-24,470
| -54% | -$3M | 0.15% | 131 |
|
|
2016
Q2 | $5.25M | Buy |
+45,000
| New | +$5.25M | 0.41% | 71 |
|
|
2016
Q1 | – | Sell |
-22,516
| Closed | -$4.3M | – | 224 |
|
|
2015
Q4 | $4.3M | Buy |
+22,516
| New | +$4.3M | 0.26% | 92 |
|